PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
10.08
-0.13 (-1.27%)
At close: Feb 27, 2026, 4:00 PM EST
9.97
-0.11 (-1.06%)
After-hours: Feb 27, 2026, 4:04 PM EST
PAVmed Revenue
PAVmed had revenue of $5.00K in the quarter ending September 30, 2025, a decrease of -99.50%. This brings the company's revenue in the last twelve months to $29.00K, down -99.28% year-over-year. In the year 2024, PAVmed had annual revenue of $3.00M with 22.15% growth.
Revenue (ttm)
$29.00K
Revenue Growth
-99.28%
P/S Ratio
496.67
Revenue / Employee
$744
Employees
39
Market Cap
14.40M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Lifeward | 24.50M |
| Vivos Therapeutics | 17.32M |
| Allurion Technologies | 17.21M |
| Beyond Air | 6.92M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Adagio Medical Holdings | 137.00K |
PAVM News
- 24 days ago - PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PRNewsWire
- 5 weeks ago - Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - Invezz
- 5 weeks ago - Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - PRNewsWire
- 2 months ago - PAVmed Announces Reverse Stock Split - PRNewsWire
- 2 months ago - Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PRNewsWire
- 3 months ago - PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 3 months ago - Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PRNewsWire
- 3 months ago - PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript - Seeking Alpha